Acute myeloid leukemia New Protocol: Revumenib with Azacitidine and Venetoclax for KMT2-Rearranged / NPM1-Mutated Ulas D. Bayraktar, MD 2025-09-08
Diffuse Large B Cell Lymphoma New Protocol: Glofitamab with R-CHOP for High-Risk DLBCL Ulas D. Bayraktar, MD 2025-09-08
Non-Small Cell Lung Cancer New Indication: Neoadjuvant Osimertinib with/without Chemo for NSCLC Ulas D. Bayraktar, MD 2025-09-08
Hodgkin Lymphoma New Protocol: Brentuximab – ECADD Chemo for Hodgkin Lymphoma Ulas D. Bayraktar, MD 2025-09-08
Pancreatic Cancer New Reference: Advanced Pancreatic Cancer Protocols Ulas D. Bayraktar, MD 2025-09-08
Prostate Cancer New REference: Talazoparib and Enzalutamide for HRR-Deficient Prostate Cancer Ulas D. Bayraktar, MD 2025-09-08
Nasopharyngeal Cancer New Drug: Penpulimab with Platinum – Gemcitabine in Advanced Nasopharyngeal Carcinoma Ulas D. Bayraktar, MD 2025-06-09
Non-Small Cell Lung Cancer New Drug: Telisotuzumab vedotin for cMET Amplified NSCLC Ulas D. Bayraktar, MD 2025-06-09
Chronic Lymphocytic Leukemia New Protocol: Zanubrutinib with Venetoclax for Untreated CLL Ulas D. Bayraktar, MD 2025-06-02
